Evidence map›Paper›PMID 42510779›Full record

ArticleGenes2026

DPYD Genotyping of Patients with Fluoropyrimidine Treatment: Results of Protocol Implementation and Outcomes of Patients Carrying Unusual DPYD Variants.

Josefa Salgado Garrido, Alba Alonso Llorente, Oscar Teijido Hermida, Juan José Beloqui Lizaso, Rosana Grández Ladrón de Guevara, Elena Mata Velasco, Ruth Vera García, Alberto Valiente Martín

Abstract read
In one paragraph

Article in Genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Josefa Salgado GarridoServicio de Genética Médica del Hospital Universitario de Navarra (HUN), 31008 Pamplona, Navarra, Spain.ORCID 0000-0002-2764-8507
Alba Alonso LlorenteServicio de Análisis Clínicos del Hospital Universitari Arnau de Vilanova de Lleida, 25198 Lleida, Catalunya, Spain.
Oscar Teijido HermidaDepartamento de Ciencias de la Salud, Universidad Pública de Navarra (UPNA), 31006 Pamplona, Navarra, Spain.ORCID 0000-0002-4600-6972
Juan José Beloqui LizasoServicio de Farmacia del Hospital Universitario de Navarra (HUN), 31008 Pamplona, Navarra, Spain.ORCID 0000-0003-1290-4050
Rosana Grández Ladrón de GuevaraServicio de Oncología Médica del Hospital Reina Sofía de Tudela, 31500 Tudela, Navarra, Spain.
Elena Mata VelascoServicio de Oncología del Hospital Universitario de Navarra (HUN), 31008 Pamplona, Navarra, Spain.
Ruth Vera GarcíaServicio de Oncología del Hospital Universitario de Navarra (HUN), 31008 Pamplona, Navarra, Spain.
Alberto Valiente MartínServicio de Genética Médica del Hospital Universitario de Navarra (HUN), 31008 Pamplona, Navarra, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dihydrouracil Dehydrogenase (NADP)FluorouracilFemaleGenotypeGenotyping TechniquesHumansLinkage DisequilibriumPolymorphism, Single NucleotideDihydrouracil Dehydrogenase (NADP)FluorouracilDPYDgenotypingHapB3rare variants

Identifiers

PMID42510779
PMCPMC13408574

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.